Comparison of Sequential therapy with standard therapy for eradication of H.Pylori infection in uremic patients
Phase 2
- Conditions
- H. Pylori infection.Other specified bacterial agents as the cause of diseases classified to other chapters
- Registration Number
- IRCT138706211241N1
- Lead Sponsor
- Mazandaran University of Medical Sciences and Health Services
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
age more than 18 years, dyspepsia during last month and positive H.pylori infection (positive rapid urease test and positive biopsy by endoscope).
Exclusion criteria: Antibiotic therapy for eradication of H.pylori, consumption of Proton Pump Inhibitor, H2 blockers, Bismuth, or NSAIDS during last month, consumption of anticoagulants, Ketoconazol or corticosteroids, history of gastric or esophageal surgery, hypersensitivity to antibiotics, negative biopsy of GI, smoking or alcohol use, pregnancy, lactation, severe heart diseases (MI, EF = 30), liver & thyroid diseases and malignancy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Eradication of H. Pylori infection. Timepoint: 3 month after treatment. Method of measurement: Stool antigen test.
- Secondary Outcome Measures
Name Time Method